Abstract
The expansion of the donor lung pool has involved an evidence-driven redefinition of acceptable donors. Proceeding with transplantation with an acceptable rather than ideal donor depends on specific patient-related and organ-related risk factors as well as the severity of recipient illness. Although the physiologic optimization of brain-dead donors has not changed significantly in recent years, the use of donor management protocols has improved procurement rates. Ex vivo lung perfusion is an increasingly viable strategy to recondition lungs that would otherwise fall below the acceptable threshold for transplant. Ex vivo perfusion trials for preservation of standard donor lungs are ongoing.
| Original language | English |
|---|---|
| Pages (from-to) | 751-759 |
| Number of pages | 9 |
| Journal | Clinics in Chest Medicine |
| Volume | 38 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2017 |
Bibliographical note
Publisher Copyright:© 2017 Elsevier Inc.
Funding
| Funders | Funder number |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | K23HL116656 |
Keywords
- Brain death
- Donor lung management
- EVLP
- Ex vivo perfusion
- Lung transplant
- Organ donor
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Fingerprint
Dive into the research topics of 'Evaluation and Management of the Potential Lung Donor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver